Table 1 Characteristics of patients in the training and validation cohorts.
Variables | Ā | Training cohort (Nā=ā193) | Validation cohort | P |
|---|---|---|---|---|
Gender | Male | 230 (83.03) | 83(85.57) | 0.741 |
| Ā | Female | 47 (16.97) | 14(14.43) | Ā |
Age | ā„ā65 | 59 (21.30) | 19(19.59) | 0.832 |
| Ā | <ā65 | 218 (78.70) | 78(80.41) | Ā |
BMI | Ā | 24.22(22.04ā26.61) | 23.98(21.97ā26.23) | 0.406 |
Alcohol abuse | Present | 62 (22.38) | 20(20.62) | 0.827 |
| Ā | Absent | 215 (77.62) | 77(79.38) | Ā |
Diabetes | Present | 39(14.08) | 10(10.30) | 0.440 |
| Ā | Absent | 238(85.92) | 87(89.70) | Ā |
Histopathological_grade | I, II | 208(75.09) | 69(71.13) | 0.528 |
| Ā | III, IV | 69(24.91) | 28(28.87) | Ā |
Tumor diameter (cm) | ā¤ā2 | 23(11.91) | 3(3.09) | 0.485 |
| Ā | >2 | 244 (88.09) | 94(96.91) | Ā |
Tumor number | ā¤ā2 | 248 (89.53) | 79(81.44) | 0.059 |
| Ā | ā„ā2 | 29 (10.47) | 18(18.56) | Ā |
MVI | Present | 128 (46.21) | 37(38.14) | 0.208 |
| Ā | Absent | 149 (53.79) | 60(61.86) | Ā |
PV | Present | 14 (5.05) | 5(5.15) | 0.979 |
| Ā | Absent | 263 (94.95) | 92(94.85) | Ā |
Liver capsule invasion | Present | 138 (49.72) | 50(51.55) | 0.861 |
| Ā | Absent | 139 (50.18) | 47 (48.45) | Ā |
Tumor satellite | Present | 31 (11.19) | 10(10.31) | 0.960 |
| Ā | Absent | 246 (88.81) | 87(89.69) | Ā |
Live cirrhosis | Present | 187 (67.51) | 56(57.73) | 0.167 |
| Ā | Absent | 90 (32.49) | 41(42.27) | Ā |
HBV | Present | 240 (86.64) | 81(83.51) | 0.703 |
| Ā | Absent | 37 (13.16) | 16(16.49) | Ā |
HBsAg | Positive | 240 (86.64) | 79(81.44) | 0.281 |
| Ā | Negative | 37 (13.16) | 18(18.56) | Ā |
AFP (ng/ml) | ā¤ā20 | 122 (44.04) | 36(37.11) | 0.285 |
| Ā | >ā20 | 155 (55.96) | 61(62.89) | Ā |
ALT (IU/l) | ā¤ā50 | 191 (68.95) | 67(69.07) | 0.999 |
| Ā | >ā50 | 86 (31.05) | 30(30.93) | Ā |
AST (IU/l) | ā¤ā35 | 172 (43.68) | 55(56.70) | 0.415 |
| Ā | >ā35 | 105 (56.32) | 42(43.30) | Ā |
TBIL(Āµmol/l) | ā¤ā17.1 | 129 (46.57) | 56(57.73) | 0.076 |
| Ā | >ā17.1 | 148 (53.43) | 41(42.27) | Ā |
ALB (g/l) | ā¤ā45 | 230 (83.94) | 89(91.75) | 0.055 |
| Ā | >ā45 | 47 (16.06) | 8(8.25) | Ā |
PLT (Ć 10^9/l) | ā¤ā100 | 32 (11.91) | 16(16.49) | 0.287 |
| Ā | >ā100 | 244 (88.09) | 81(83.51) | Ā |
PT (s) | Ā | 10.5(9.8ā11.1) | 10.5(10ā11) | 0.969 |
NEUT (Ć 10^9/l) | Ā | 3.06(2.39ā4.25) | 2.87(2.10ā3.79) | 0.062 |
Lymphocyte | Ā | 1.63(1.24ā2.16) | 1.58(1.17ā1.94) | 0.257 |
Cr | Ā | 68(54ā83) | 13(12.5ā13.5) | 0.454 |
ChildāPugh | A | 266 (96.03) | 91(93.81) | 0.537 |
| Ā | B | 11(3.97) | 6(6.19) | Ā |
CNLC | I, II | 143(51.62) | 53(54.64) | 0.694 |
| Ā | III, IV | 134(48.38) | 44(45.36) | Ā |
